SCIEX and Metabolon Launch the Lipidyzer™ Platform for Complete Lipid Analysis
Game-changing solution offers rapid quantitation of over a thousand lipids and signals the arrival of next-generation lipidomics
FRAMINGHAM, MA and RESEARCH TRIANGLE PARK, N.C. – June 1, 2015 – SCIEX, a global leader in life science analytical technologies, and Metabolon, Inc., the global leader in metabolomics, announced today that they have entered into a multi-year collaboration. The Lipidyzer™ Platform, the first truly integrated solution for accurate and meaningful next-generation lipidomics, is the first product resulting from the collaboration. The Lipidyzer Platform enables scientists to rapidly identify and quantify over one thousand lipid molecular species and is expected to play a role in researching diseases including cardiovascular disease, diabetes and neurodegenerative disorders. Built on SCIEX technology, and powered by Metabolon know-how, the Lipidyzer Platform includes newly developed sample preparation kits, separations technologies, mass spectrometry, software, and data analysis services.
Lipidomics researchers currently rely on fragmented mass spectrometry hardware and software systems for lipid analysis, resulting in inefficient workflows that cannot be reliably scaled up or used by a non-expert. Furthermore, lipid analysis typically involves complicated sample preparation techniques and challenging sample analysis, with many isobaric and near isobaric interferences that can be particularly problematic for lipid identification and accurate quantitation. The all-in-one Lipidyzer Platform includes proprietary SelexION™ Technology to overcome these lipid separation challenges, and delivers highly accurate and sensitive quantitation across many common lipid classes. Sample preparation is simplified and standardized with sample preparation kits that have been optimized by leading lipidomics experts, improving the reproducibility and reliability of research data, as well as saving time.
“This is the first integrated scientific analyzer that’s dedicated to quantitative lipid profiling and it will play a crucial role in making next-generation lipidomics available to the broader scientific community,”said Aaron Hudson, Senior Director of Academic and Clinical Research Business of SCIEX. “This platform does more than provide data; it’s a game-changing solution, as it actually delivers actionable biological information that can be shared through our online cloud-based tools, helping to advance lipid-based disease research.”
The sample-to-biology platform includes Metabolon’s comprehensive custom-developed software for relevant interpretation and visualization of data from a biology and disease-significance perspective. Metabolon, a leader in the science of metabolomics since 2000, also provides expert consultancy services to help users with data analysis and interpretation.
“The unique ability of the Lipidyzer to generate quantitative, specific and complete lipidomic data allows for an accurate mapping of the results to lipid metabolic pathways,” commented Steve Watkins, Ph.D., Chief Technology Officer at Metabolon. “Once researchers have this technology in their hands, I am sure our knowledge of the fundamental role of lipids in many aspects of health and disease will expand tremendously. We’re proud to have co-developed the Lipidyzer Platform; it provides a real advance in lipidomics research.”
Learn more about the Lipidyzer Platform.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit www.sciex.com.
For research use only. Not for use in diagnostic procedures. RUO-MKT-12-2164
AB Sciex is operating as SCIEX.
© 2015 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license.
Metabolon, Inc. is the world’s leading life sciences company focused on metabolomics – an integrative, powerful phenotyping technology for assessing health. Its proprietary platforms and informatics systems are delivering biomarker discoveries, innovative diagnostic tests, breakthroughs in personalized medicine, and robust partnerships in genomics-based health initiatives. Metabolon’s expertise is also accelerating research and product development for more than 650 clients across the pharmaceutical, biotechnology, consumer products, agriculture and nutrition industries, as well as academic and government organizations. Founded in 2000 and headquartered in Research Triangle Park, North Carolina, the company has conducted over 4,000 independent and collaborative studies, resulting in nearly 500 peer-reviewed publications. For more information, please visit www.metabolon.com or follow us on LinkedIn or Twitter.
Stacey Sicurella, Manager Global Public Relations and Brand, SCIEX
Patrick Farrell, Sniper Public Relations on Behalf of SCIEX
Robin Fastenau, Vice President Corporate Communications